The December 2023 issue of the HERU newsletter is available. In the newsletter we highlight a new project we are involved to examine the use of the hormone progesterone to treat women at risk of a threatened miscarriage, and update on some studies previously featured in the newsletter:
- The Glaucoma Risk Prediction in Ocular Hypertension (GRIP) project on monitoring for glaucoma, and a project to reduce the use of 'street drugs' in Scotland have both recently completed.
- We report from a workshop delivered as part of a Global Health Research Group programme to improve mental wellbeing in children and adolescents in Sub-Saharan Africa.
The newsletter includes our usual updates on events, including news of dates for our 2024 discrete choice experiment (DCE) courses, and staffing news.